Rencuzogullari, O. Et Al. 2020. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells. JOURNAL OF CELLULAR BIOCHEMISTRY , vol.121, no.1 , 508-523.

Rencuzogullari, O., Yerlikaya, P. O., Gurkan, A., Arisan, E. D., & Telci, D., (2020). Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells. JOURNAL OF CELLULAR BIOCHEMISTRY , vol.121, no.1, 508-523.

Rencuzogullari, Ozge Et Al. "Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells," JOURNAL OF CELLULAR BIOCHEMISTRY , vol.121, no.1, 508-523, 2020

Rencuzogullari, Ozge Et Al. "Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells." JOURNAL OF CELLULAR BIOCHEMISTRY , vol.121, no.1, pp.508-523, 2020

Rencuzogullari, O. Et Al. (2020) . "Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells." JOURNAL OF CELLULAR BIOCHEMISTRY , vol.121, no.1, pp.508-523.

@article{article, author={Ozge Rencuzogullari Et Al. }, title={Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells}, journal={JOURNAL OF CELLULAR BIOCHEMISTRY}, year=2020, pages={508-523} }